Previous 10 | Next 10 |
Gainers: [[DPW]] +46.3%. [[PFSW]] +39.9%. [[APYX]] +26.7%. [[MAXR]] +7.9%. [[SPCE]] +7.4%.Losers: [[SMLP]] -10.3%. [[VIRC]] -9.5%. [[VOLT]] -7.6%. [[TOUR]] -5.4%. [[HA]] -4.9%. For further details see: DPW, PFSW, APYX and VOLT among after-hours movers
Apyx Medical (APYX) shares shoot 26% after market as it reports Q4 preliminary total revenue in a range of ~$10.9-$11.3M, up ~30%-35% Y/Y.Q4 Advanced Energy revenue in a range of ~$9.5-$9.8M, up ~39%-43% Y/Y and OEM revenue ~$1.35-$1.45M, down ~5%-11% Y/Y. FY 2020: Total revenue in ...
Advanced Energy Sales of approximately $9.5 to $9.8 million in Q4, up 39% to 43% year-over-year Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and s...
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announc...
InMode is an outperformer and leader in the growing medical aesthetic devices industry. Its products are made for a variety of purposes including liposuction, skin rejuvenation, cellulite treatment, and more. InMode is an asset-light business with high returns on capital and a flawles...
Apyx Medical (APYX) has received FDA approval to begin Phase II of U.S. IDE clinical study evaluating the use of its Renuvion technology in skin laxity procedures in the neck and submental region. “The approved supplement included changes to the treatment protocol based on feedback fro...
Gainers: [[CANG]] +30.9%. [[DPW]] +14.3%. [[APYX]] +14.2%. [[ALT]] +11.4%. [[FCEL]] +9.1%.Losers: [[DAC]] -13.1%. [[RENN]] -10.8%. [[BLDP]] -7.3%. [[RGLD]] -7.1%. [[FF]] -5.9%. For further details see: DPW, CANG, DAC and RENN among after-hours movers
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today a...
The following slide deck was published by Apyx Medical Corporation in conjunction with this event. For further details see: Apyx Medical (APYX) Investor Presentation - Slideshow
Apyx Medical Corporation (APYX) Q3 2020 Earnings Conference Call November 9, 2020 08:00 ET Company Participants Charlie Goodwin - President and Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants David Turkaly - JMP Securities Matthew O’Brien - Pipe...
News, Short Squeeze, Breakout and More Instantly...
Apyx Medical Corporation Company Name:
APYX Stock Symbol:
NASDAQ Market:
Apyx Medical Corporation Website:
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion ® , today announced that financial results for the second quarter of fiscal year 2024 will be relea...
Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health PR Newswire Renuvion is the only device FDA-cleared for contracting subcutaneous tissue CLEARWATER, Fla. ...